Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer
- Ryosuke Uekusa
- , Akira Yokoi
- , Eri Watanabe
- , Kosuke Yoshida
- , Masato Yoshihara
- , Satoshi Tamauchi
- , Yusuke Shimizu
- , Yoshiki Ikeda
- , Nobuhisa Yoshikawa
- , Kaoru Niimi
- , Shiro Suzuki
- , Hiroaki Kajiyama
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Citations
(Scopus)